Aortic Aneurysms
Conditions
Keywords
Aorta, Aneurysm, endovascular, stent-graft
Brief summary
The aim of this study is to prospectively compare the perioperative mortality severe morbidity and the costs of endovascular versus conventional surgical repair of pararenal, supra-renal and type 4 THORACO-abdominal aortic aneurysms. The primary goal of the study is to demonstrate a significant drop in 30-day mortality and life threatening morbidity in the endovascular arm of the study. Our hypothesis, derived from the literature, that the average 30-days mortality is 3% after endovascular repair and 10% after open surgery justifies the design of a prospective study between endovascular therapy (250 patients (amendment) treated in 8 University hospitals with significant experience of the technique) and open repair (660 similar patients analyzed form the national database of the MOH).
Detailed description
The aim of this study is to prospectively compare the perioperative mortality severe morbidity and the costs of endovascular versus conventional surgical repair of pararenal, supra-renal and type 4 THORACO-abdominal aortic aneurysms. The primary goal of the study is to demonstrate a significant drop in 30-day mortality and life threatening morbidity in the endovascular arm of the study. Our hypothesis, derived from the literature, that the average 30-days mortality is 3% after endovascular repair and 10% after open surgery justifies the design of a prospective study between endovascular therapy (250 patients (amendment) treated in 8 University hospitals with significant experience of the technique) and open repair (660 similar patients analyzed form the national database of the MOH). In-hospital morbidity are similarly expected to be lower in the endovascular group. We also wish to demonstrate that endovascular repair does not represent a significant over-cost, as compared to open repair. The cost of the implantable medical device (IMD), of follow-up screening, and of eventual repeated interventions should be compensated by a reduced stay in intensive care unit ICU, and by a reduced in-hospital length of stay.
Interventions
Insertion via bilateral femoral access, stent-graft deployment under fluoroscopic guidance, complementary stenting of visceral arteries, control angiogram
aortic replacement with revascularization of visceral arteries
Sponsors
Study design
Eligibility
Inclusion criteria
The following anatomical inclusion criteria must be met: * Absence of significant angulations (\< 60°) of aorta or of iliac arteries * Absence of tight stenosis (\>70%) of more than one target artery (renal or visceral artery to be perfused from the side holes of the stent-graft) * Diameter of target arteries over 5 mm * Iliac and femoral arteries allowing insertion of the delivery system (\> 7 mm) or suitable for insertion of an access conduit
Exclusion criteria
* Limited expected life expectancy * Emergency cases * Refuse to participate to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 30-day postoperative mortality | 30-day postoperative |
Secondary
| Measure | Time frame |
|---|---|
| Length of Intensive Care Unit (ICU) stay | 30-day postoperative |
| Length of Hospital stay | 30-day postoperative |
| Overall cost | 30-day postoperative |
| complications | 30-day postoperative |
| Global survival | 2-year follow up |
| Mortality in touch with aneurysm | 2-year follow up |
| Annual cost (1 month, 6 month, 1 year and 2 year Follow-up screening ) | 2-year follow up |
| Reinterventions | 2-year follow up |
Countries
France